View Older Stories View More Recent Stories

Feb 10, 2021 08:15AM Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021
Feb 3, 2021 07:13AM Veracyte (VCYT) Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
Feb 3, 2021 07:13AM Veracyte (VCYT) to Acquire Decipher Biosciences
Feb 3, 2021 07:05AM Veracyte to Acquire Decipher Biosciences
Feb 3, 2021 07:00AM Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
Jan 6, 2021 02:00PM Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference
Dec 22, 2020 08:15AM Veracyte (VCYT), Bayer Announce Precision Oncology Collaboration in Thyroid Cancer
Dec 22, 2020 08:15AM Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
Dec 22, 2020 08:15AM Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
Dec 21, 2020 08:15AM Veracyte (VCYT) Announces ISO 13485:2016 Certification for Its In Vitro Diagnostics Quality Management System
Dec 21, 2020 08:15AM Veracyte Announces ISO 13485:2016 Certification for Its In Vitro Diagnostics Quality Management System
Dec 16, 2020 12:00PM Veracyte (VCYT) Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests
Dec 16, 2020 12:00PM Veracyte Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests
Dec 15, 2020 08:16AM Veracyte (VCYT) Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson
Dec 15, 2020 08:15AM Veracyte Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson
Dec 3, 2020 02:30PM Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020
Nov 23, 2020 04:05PM Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 17, 2020 08:35AM Veracyte (VCYT) Announces New General Manager Structure
Nov 17, 2020 08:30AM Veracyte Announces New General Manager Structure to Advance Global Expansion
Nov 5, 2020 03:05AM Prosigna Breast Cancer Assay Now Approved for Reimbursement in Germany
Nov 2, 2020 04:05PM Veracyte Announces Third Quarter 2020 Financial Results
Oct 30, 2020 08:17AM Veracyte (VCYT) Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test’s Genomic Underpinning Drives Prognostic Performance
Oct 30, 2020 08:15AM Veracyte Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test’s Genomic Underpinning Drives Prognostic Performance
Oct 22, 2020 04:05PM Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing Classifier
Oct 19, 2020 08:16AM Veracyte (VCYT) Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST
Oct 19, 2020 08:15AM Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020
Oct 14, 2020 04:05PM Veracyte Announces Two Presentations to Be Shared at CHEST Annual Meeting 2020
Oct 7, 2020 08:15AM Veracyte to Release Third Quarter 2020 Financial Results on November 2, 2020
Sep 24, 2020 08:18AM Veracyte (VCYT) Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services
Sep 24, 2020 08:15AM Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services
Sep 15, 2020 04:30PM Veracyte to Present at Two Investor Conferences
Sep 14, 2020 01:45PM Veracyte Announces Promotion of Richard T. Kloos, M.D. To Executive Medical Director
Sep 11, 2020 08:15AM Veracyte (VCYT) Announces Initiation of Consensus Study Exploring Medical Utility of Multiple Breast Cancer Genomic Tests
Sep 11, 2020 08:15AM Veracyte Announces Initiation of Consensus Study Exploring Medical Utility of Multiple Breast Cancer Genomic Tests
Sep 4, 2020 08:15AM Veracyte to Present at Upcoming Investor Conferences
Aug 24, 2020 08:15AM Veracyte Named a San Francisco Bay Area “Top Workplace” for Seventh Consecutive Year
Aug 5, 2020 04:15PM Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases
Aug 5, 2020 08:18AM Veracyte (VCYT) Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST
Aug 5, 2020 08:15AM Veracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST
Jul 30, 2020 04:05PM Veracyte Announces Second Quarter 2020 Financial Results
Jul 30, 2020 08:15AM Veracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians’ Ability to Diagnose IPF Without Surgery
Jul 29, 2020 08:16AM Veracyte (VCYT), MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Jul 29, 2020 08:15AM Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Jul 27, 2020 08:15AM Veracyte Appoints Jens Holstein to Board of Directors and James (Jim) Erlinger as Executive Vice President, General Counsel and Secretary
Jul 16, 2020 08:15AM Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020
Jun 11, 2020 07:31AM Veracyte (VCYT) Announces Clinical Utility Study Published in CHEST Demonstrates Envisia Genomic Classifier's Ability to Improve IPF Diagnosis
Jun 11, 2020 07:30AM Veracyte Announces Clinical Utility Study Published in CHEST Demonstrates Envisia Genomic Classifier’s Ability to Improve IPF Diagnosis
Jun 9, 2020 08:15AM Veracyte Announces De Novo Classification Request to FDA for the nCounter Dx LymphMark Assay
May 27, 2020 08:15AM Veracyte to Present at the William Blair 40th Annual Growth Stock Conference
May 21, 2020 08:15AM Veracyte to Present at the Jefferies Virtual Healthcare Conference
View More Recent Stories View Older Stories